Correlating transcriptional networks to breast cancer survival: A large-scale coexpression analysis

Carcinogenesis

Volumn 34, Issue 10, 2013, Pages 2300-2308

  Clarke, Colin ^a   Madden, Stephen F ^a   Doolan, Padraig ^a   Aherne, Sinead T ^a   Joyce, Helena ^a   O'Driscoll, Lorraine ^b   Gallagher, William M ^c   Hennessy, Bryan T ^d   Moriarty, Michael ^a   Crown, John ^a   Kennedy, Susan ^e   Clynes, Martin ^a  

^a DUBLIN CITY UNIVERSITY   (Ireland)

^b TRINITY COLLEGE DUBLIN   (Ireland)

^c UNIVERSITY COLLEGE DUBLIN   (Ireland)

^d BEAUMONT HOSPITAL   (Ireland)

^e ROYAL VICTORIA EYE AND EAR HOSPITAL   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; INWARDLY RECTIFYING POTASSIUM CHANNEL; MESSENGER RNA; UBIQUITIN CONJUGATING ENZYME E2; UBIQUITIN CONJUGATING ENZYME E2S; UNCLASSIFIED DRUG;

ARTICLE; BREAST CANCER; CANCER GRADING; CANCER SURVIVAL; CELL PROLIFERATION; DISEASE FREE SURVIVAL; DISTANT METASTASIS FREE SURVIVAL; GENE CLUSTER; GENE CONTROL; GENE EXPRESSION; GENETIC ANALYSIS; GENETIC TRANSCRIPTION; HUMAN; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS;

BREAST NEOPLASMS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE REGULATORY NETWORKS; GENOME-WIDE ASSOCIATION STUDY; HUMANS; MULTIGENE FAMILY; REPRODUCIBILITY OF RESULTS; TRANSCRIPTION, GENETIC;

EID: 84885131104     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgt208     Document Type: Article

References (54)

1. Goldhirsch, A. et al. (2009) Thresholds for therapies: highlights of the St Gallen International Expert Consensus on the primary therapy of early breast cancer 2009. Ann. Oncol., 20, 1319-1329.
2. Perou, C.M. et al. (2000) Molecular portraits of human breast tumours. Nature, 406, 747-752.
3. Curtis, C. et al. (2012) The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups. Nature, 486, 346-352.
4. Network, T.C.G.A. (2012) Comprehensive molecular portraits of human breast tumours. Nature, 490, 61-70.
5. van't Veer, L.J. et al. (2002) Gene expression profiling predicts clinical outcome of breast cancer. Nature, 415, 530-536.
6. Paik, S. et al. (2004) A multigene assay to predict recurrence of tamoxifentreated, node-negative breast cancer. N. Engl. J. Med., 351, 2817-2826.
7. Schmid, P.R. et al. (2012) Making sense out of massive data by going beyond differential expression. Proc. Natl Acad. Sci. USA, 109, 5594-5599.
8. Rhodes, D.R. et al. (2004) Large-scale meta-analysis of cancer microarray data identifies common transcriptional profiles of neoplastic transformation and progression. Proc. Natl Acad. Sci. USA, 101, 9309-9314.
9. Xu, L. et al. (2007) Large-scale integration of cancer microarray data identifies a robust common cancer signature. BMC Bioinformatics, 8, 275.
10. Botling, J. et al. (2013) Biomarker discovery in non-small cell lung cancer: integrating gene expression profiling, meta-analysis, and tissue microarray validation. Clin. Cancer Res., 19, 194-204.
11. Alles, M.C. et al. (2009) Meta-analysis and gene set enrichment relative to er status reveal elevated activity of MYC and E2F in the "basal" breast cancer subgroup. PLoS One, 4, e4710.
12. Mehra, R. et al. (2005) Identification of GATA3 as a breast cancer prognostic marker by global gene expression meta-analysis. Cancer Res., 65, 11259-11264.
13. Madden, S.F. et al. (2013) BreastMark: an integrated approach to mining publicly available transcriptomic datasets relating to breast cancer outcome. Breast Cancer Res., in press.
14. Györffy, B. et al. (2010) An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients. Breast Cancer Res. Treat., 123, 725-731.
15. Stuart, J.M. et al. (2003) A gene-coexpression network for global discovery of conserved genetic modules. Science, 302, 249-255.
16. Oldham, M.C. et al. (2006) Conservation and evolution of gene coexpression networks in human and chimpanzee brains. Proc. Natl Acad. Sci. USA, 103, 17973-17978.
17. Oldham, M.C. et al. (2008) Functional organization of the transcriptome in human brain. Nat. Neurosci., 11, 1271-1282.
18. Clarke, C. et al. (2011) Large scale microarray profiling and coexpression network analysis of CHO cells identifies transcriptional modules associated with growth and productivity. J. Biotechnol., 155, 350-359.
19. Wang, L. et al. (2009) Gene networks and microRNAs implicated in aggressive prostate cancer. Cancer Res., 69, 9490-9497.
20. Horvath, S. et al. (2006) Analysis of oncogenic signaling networks in glioblastoma identifies ASPM as a molecular target. Proc. Natl Acad. Sci. USA, 103, 17402-17407.
21. Wirapati, P. et al. (2008) Meta-analysis of gene expression profiles in breast cancer: toward a unified understanding of breast cancer subtyping and prognosis signatures. Breast Cancer Res., 10, R65.
22. Zhang, B. et al. (2005) A general framework for weighted gene co-expression network analysis. Stat. Appl. Genet. Mol. Biol., 4, Article 17.
23. Desmedt, C. et al. (2009) The Gene expression Grade Index: a potential predictor of relapse for endocrine-treated breast cancer patients in the BIG 1-98 trial. BMC Med. Genomics, 2, 40.
24. Desmedt, C. et al. (2007) Strong time dependence of the 76-gene prognostic signature for node-negative breast cancer patients in the TRANSBIG multicenter independent validation series. Clin. Cancer Res., 13, 3207-3214.
25. Loi, S. et al. (2008) Predicting prognosis using molecular profiling in estrogen receptor-positive breast cancer treated with tamoxifen. BMC Genomics, 9, 239.
26. Miller, L.D. et al. (2005) An expression signature for p53 status in human breast cancer predicts mutation status, transcriptional effects, and patient survival. Proc. Natl Acad. Sci. USA, 102, 13550-13555.
27. Pawitan, Y. et al. (2005) Gene expression profiling spares early breast cancer patients from adjuvant therapy: derived and validated in two population- based cohorts. Breast Cancer Res., 7, R953-R964.
28. Sabatier, R. et al. (2011) A gene expression signature identifies two prognostic subgroups of basal breast cancer. Breast Cancer Res. Treat., 126, 407-420.
29. Schmidt, M. et al. (2008) The humoral immune system has a key prognostic impact in node-negative breast cancer. Cancer Res., 68, 5405-5413.
30. Wang, Y. et al. (2005) Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer. Lancet, 365, 671-679.
31. Zhang, Y. et al. (2009) The 76-gene signature defines high-risk patients that benefit from adjuvant tamoxifen therapy. Breast Cancer Res. Treat., 116, 303-309.
32. Kao, K.J. et al. (2011) Correlation of microarray-based breast cancer molecular subtypes and clinical outcomes: implications for treatment optimization. BMC Cancer, 11, 143.
33. Bos, P.D. et al. (2009) Genes that mediate breast cancer metastasis to the brain. Nature, 459, 1005-1009.
34. Sircoulomb, F. et al. (2010) Genome profiling of ERBB2-amplified breast cancers. BMC Cancer, 10, 539.
35. Nagalla, S. et al. (2013) Interactions between immunity, proliferation and molecular subtype in breast cancer prognosis. Genome Biol., 14, R34.
36. Irizarry, R.A. et al. (2003) Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics, 4, 249-264.
37. Johnson, W.E. et al. (2007) Adjusting batch effects in microarray expression data using empirical Bayes methods. Biostatistics, 8, 118-127.
38. Sorlie, T. et al. (2003) Repeated observation of breast tumor subtypes in independent gene expression data sets. Proc. Natl Acad. Sci. USA, 100, 8418-8423.
39. Hu, Z. et al. (2006) The molecular portraits of breast tumors are conserved across microarray platforms. BMC Genomics, 7, 96.
40. Parker, J.S. et al. (2009) Supervised risk predictor of breast cancer based on intrinsic subtypes. J. Clin. Oncol., 27, 1160-1167.
41. Martinez, V. et al. (2008) Drug metabolism-related genes as potential biomarkers: analysis of expression in normal and tumour breast tissue. Breast Cancer Res. Treat., 110, 521-530.
42. Langfelder, P. et al. (2008) WGCNA: an R package for weighted correlation network analysis. BMC Bioinformatics, 9, 559.
43. Mason, M.J. et al. (2009) Signed weighted gene co-expression network analysis of transcriptional regulation in murine embryonic stem cells. BMC Genomics, 10, 327.
44. Ravasz, E. et al. (2002) Hierarchical organization of modularity in metabolic networks. Science, 297, 1551-1555.
45. Horvath, S. et al. (2008) Geometric interpretation of gene coexpression network analysis. PLoS Comput. Biol., 4, e1000117.
46. Dannenfelser, R. et al. (2011) FNV: light-weight flash-based network and pathway viewer. Bioinformatics, 27, 1181-1182.
47. Teschendorff, A.E. et al. (2007) An immune response gene expression module identifies a good prognosis subtype in estrogen receptor negative breast cancer. Genome Biol., 8, R157.
48. Vanaja, D.K. et al. (2009) PDLIM4, an actin binding protein, suppresses prostate cancer cell growth. Cancer Invest., 27, 264-272.
49. Xu, J. et al. (2012) Methylation of HIN-1, RASSF1A, RIL and CDH13 in breast cancer is associated with clinical characteristics, but only RASSF1A methylation is associated with outcome. BMC Cancer, 12, 243.
50. Koo, C.Y. et al. (2012) FOXM1: From cancer initiation to progression and treatment. Biochim. Biophys. Acta, 1819, 28-37.
51. Hedman, H. et al. (2007) LRIG inhibitors of growth factor signalling - double- edged swords in human cancer? Eur. J. Cancer, 43, 676-682.
52. Krig, S.R. et al. (2011) Lrig1 is an estrogen-regulated growth suppressor and correlates with longer relapse-free survival in ERa-positive breast cancer. Mol. Cancer Res., 9, 1406-1417.
53. Bai, L. et al. (2012) LRIG1 modulates cancer cell sensitivity to Smac mimetics by regulating TNFa expression and receptor tyrosine kinase signaling. Cancer Res., 72, 1229-1238.
54. Powell, A.E. et al. (2012) The pan-ErbB negative regulator Lrig1 is an intestinal stem cell marker that functions as a tumor suppressor. Cell, 149, 146-158.